New safety warnings are coming for two common medicines, doxycycline and carbimazole. Indian drug regulators have identified potential mental health side effects for doxycycline. Carbimazole will now carry stronger warnings about a rare but serious blood disorder. Manufacturers must update prescribing information. These changes aim to improve patient safety by highlighting important risks.
RSS News
Economic times
0 thoughts on “Thyroid, antibiotic drugs face fresh safety warnings after national review”
Leave a Reply
Your email address will not be published. Required fields are marked *
RECENT NEWS
- 27 Indian-flagged ships remain stranded in Persian Gulf, one starts moving: Government official
- West Asia crisis: The Indians caught in the crossfire
- Iran clears safe passage to Indian ships, vessel with 40,000 metric tonnes of LPG crosses Strait of Hormuz
- IndiGo flights to get costlier as airline announces fuel charge upto Rs 2300 amid West Asia conflict
- Google Maps has two new features, now you can ask the way by speaking with the help of AI.
